Cargando…
CD4-positive diffuse large B-cell lymphoma: A variant with aggressive clinical potential
CD4 expression is rare in diffuse large B-cell lymphoma (DLBCL), with 4 previously reported cases. Its significance is uncertain. We report five patients with CD4(+) DLBCL and one CD4(+) primary mediastinal large B-cell lymphoma. Cases were identified by searching the electronic database of the depa...
Autores principales: | Hussaini, Mohammad O, Kreisel, Friederike H, Hassan, Anjum, Nguyen, TuDung T, Frater, John L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031925/ https://www.ncbi.nlm.nih.gov/pubmed/27679780 http://dx.doi.org/10.5662/wjm.v6.i3.181 |
Ejemplares similares
-
Acute EBV infection masquerading as "In-situ Follicular Lymphoma": a pitfall in the differential diagnosis of this entity
por: Gru, Alejandro A, et al.
Publicado: (2013) -
Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major Central-Midwestern United States tertiary care medical center
por: Warrick, Joshua, et al.
Publicado: (2012) -
Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas
por: Dubanet, Lydie, et al.
Publicado: (2015) -
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
por: Brault, L, et al.
Publicado: (2012) -
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
por: Visco, Carlo, et al.
Publicado: (2017)